List of Tables
Table 1. Global Drug Elutable Microspheres Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Drug Elutable Microspheres Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Drug Elutable Microspheres Market Competitive Situation by Manufacturers in 2024
Table 4. Global Drug Elutable Microspheres Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Drug Elutable Microspheres Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Drug Elutable Microspheres Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Drug Elutable Microspheres Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Drug Elutable Microspheres Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Drug Elutable Microspheres, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Elutable Microspheres, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Elutable Microspheres, Product Type & Application
Table 12. Global Key Manufacturers of Drug Elutable Microspheres, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Elutable Microspheres by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Elutable Microspheres as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Elutable Microspheres Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Drug Elutable Microspheres Sales by Region (2020-2025) & (K Units)
Table 18. Global Drug Elutable Microspheres Sales Market Share by Region (2020-2025)
Table 19. Global Drug Elutable Microspheres Sales by Region (2026-2031) & (K Units)
Table 20. Global Drug Elutable Microspheres Sales Market Share by Region (2026-2031)
Table 21. Global Drug Elutable Microspheres Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Drug Elutable Microspheres Revenue Market Share by Region (2020-2025)
Table 23. Global Drug Elutable Microspheres Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Drug Elutable Microspheres Revenue Market Share by Region (2026-2031)
Table 25. North America Drug Elutable Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Drug Elutable Microspheres Sales by Country (2020-2025) & (K Units)
Table 27. North America Drug Elutable Microspheres Sales by Country (2026-2031) & (K Units)
Table 28. North America Drug Elutable Microspheres Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Drug Elutable Microspheres Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Drug Elutable Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Drug Elutable Microspheres Sales by Country (2020-2025) & (K Units)
Table 32. Europe Drug Elutable Microspheres Sales by Country (2026-2031) & (K Units)
Table 33. Europe Drug Elutable Microspheres Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Drug Elutable Microspheres Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Drug Elutable Microspheres Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Drug Elutable Microspheres Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Drug Elutable Microspheres Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Drug Elutable Microspheres Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Drug Elutable Microspheres Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Drug Elutable Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Drug Elutable Microspheres Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Drug Elutable Microspheres Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Drug Elutable Microspheres Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Drug Elutable Microspheres Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Drug Elutable Microspheres Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Drug Elutable Microspheres Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Drug Elutable Microspheres Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Drug Elutable Microspheres Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Drug Elutable Microspheres Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Drug Elutable Microspheres Sales (K Units) by Type (2020-2025)
Table 51. Global Drug Elutable Microspheres Sales (K Units) by Type (2026-2031)
Table 52. Global Drug Elutable Microspheres Sales Market Share by Type (2020-2025)
Table 53. Global Drug Elutable Microspheres Sales Market Share by Type (2026-2031)
Table 54. Global Drug Elutable Microspheres Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Drug Elutable Microspheres Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Drug Elutable Microspheres Revenue Market Share by Type (2020-2025)
Table 57. Global Drug Elutable Microspheres Revenue Market Share by Type (2026-2031)
Table 58. Global Drug Elutable Microspheres Price (US$/Unit) by Type (2020-2025)
Table 59. Global Drug Elutable Microspheres Price (US$/Unit) by Type (2026-2031)
Table 60. Global Drug Elutable Microspheres Sales (K Units) by Application (2020-2025)
Table 61. Global Drug Elutable Microspheres Sales (K Units) by Application (2026-2031)
Table 62. Global Drug Elutable Microspheres Sales Market Share by Application (2020-2025)
Table 63. Global Drug Elutable Microspheres Sales Market Share by Application (2026-2031)
Table 64. Global Drug Elutable Microspheres Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Drug Elutable Microspheres Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Drug Elutable Microspheres Revenue Market Share by Application (2020-2025)
Table 67. Global Drug Elutable Microspheres Revenue Market Share by Application (2026-2031)
Table 68. Global Drug Elutable Microspheres Price (US$/Unit) by Application (2020-2025)
Table 69. Global Drug Elutable Microspheres Price (US$/Unit) by Application (2026-2031)
Table 70. Terumo Company Information
Table 71. Terumo Description and Business Overview
Table 72. Terumo Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Terumo Drug Elutable Microspheres Product
Table 74. Terumo Recent Developments/Updates
Table 75. Balton Company Information
Table 76. Balton Description and Business Overview
Table 77. Balton Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Balton Drug Elutable Microspheres Product
Table 79. Balton Recent Developments/Updates
Table 80. Boston Scientific Company Information
Table 81. Boston Scientific Description and Business Overview
Table 82. Boston Scientific Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Boston Scientific Drug Elutable Microspheres Product
Table 84. Boston Scientific Recent Developments/Updates
Table 85. Cook Medical Company Information
Table 86. Cook Medical Description and Business Overview
Table 87. Cook Medical Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Cook Medical Drug Elutable Microspheres Product
Table 89. Cook Medical Recent Developments/Updates
Table 90. Merit Medical Company Information
Table 91. Merit Medical Description and Business Overview
Table 92. Merit Medical Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merit Medical Drug Elutable Microspheres Product
Table 94. Merit Medical Recent Developments/Updates
Table 95. Varian Medical Company Information
Table 96. Varian Medical Description and Business Overview
Table 97. Varian Medical Drug Elutable Microspheres Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Varian Medical Drug Elutable Microspheres Product
Table 99. Varian Medical Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Drug Elutable Microspheres Distributors List
Table 103. Drug Elutable Microspheres Customers List
Table 104. Drug Elutable Microspheres Market Trends
Table 105. Drug Elutable Microspheres Market Drivers
Table 106. Drug Elutable Microspheres Market Challenges
Table 107. Drug Elutable Microspheres Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Drug Elutable Microspheres
Figure 2. Global Drug Elutable Microspheres Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Drug Elutable Microspheres Market Share by Type: 2024 & 2031
Figure 4. Volume 2ml Product Picture
Figure 5. Volume 4ml Product Picture
Figure 6. Others Product Picture
Figure 7. Global Drug Elutable Microspheres Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Drug Elutable Microspheres Market Share by Application: 2024 & 2031
Figure 9. Oncology
Figure 10. Vascular Embolism
Figure 11. Others
Figure 12. Global Drug Elutable Microspheres Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Drug Elutable Microspheres Market Size (2020-2031) & (US$ Million)
Figure 14. Global Drug Elutable Microspheres Sales (2020-2031) & (K Units)
Figure 15. Global Drug Elutable Microspheres Average Price (US$/Unit) & (2020-2031)
Figure 16. Drug Elutable Microspheres Report Years Considered
Figure 17. Drug Elutable Microspheres Sales Share by Manufacturers in 2024
Figure 18. Global Drug Elutable Microspheres Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Drug Elutable Microspheres Players: Market Share by Revenue in Drug Elutable Microspheres in 2024
Figure 20. Drug Elutable Microspheres Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Drug Elutable Microspheres Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Drug Elutable Microspheres Sales Market Share by Country (2020-2031)
Figure 23. North America Drug Elutable Microspheres Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Drug Elutable Microspheres Sales Market Share by Country (2020-2031)
Figure 27. Europe Drug Elutable Microspheres Revenue Market Share by Country (2020-2031)
Figure 28. Germany Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Drug Elutable Microspheres Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Drug Elutable Microspheres Revenue Market Share by Region (2020-2031)
Figure 35. China Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Taiwan Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Philippines Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Drug Elutable Microspheres Sales Market Share by Country (2020-2031)
Figure 46. Latin America Drug Elutable Microspheres Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Drug Elutable Microspheres Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Drug Elutable Microspheres Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. U.A.E Drug Elutable Microspheres Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Drug Elutable Microspheres by Type (2020-2031)
Figure 56. Global Revenue Market Share of Drug Elutable Microspheres by Type (2020-2031)
Figure 57. Global Drug Elutable Microspheres Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Drug Elutable Microspheres by Application (2020-2031)
Figure 59. Global Revenue Market Share of Drug Elutable Microspheres by Application (2020-2031)
Figure 60. Global Drug Elutable Microspheres Price (US$/Unit) by Application (2020-2031)
Figure 61. Drug Elutable Microspheres Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed